Chapter 7: Reproductive Health, Menstrual Disorders, & STIs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Okay, let's unpack this.

If you are preparing for a career in maternal child nursing,

reproductive health isn't just another chapter in a textbook.

It is probably the most foundational piece of women's health you're ever going to encounter.

Oh, absolutely.

It's huge.

It's not just about birth, right?

It's about this entire dynamic system, the anatomy, the cycles, how hormones are constantly fluctuating and how lifestyle and environment play into all of that.

Exactly.

You've got this really complex physiology that is, at the same time, intersecting with a deeply personal patient experience.

So our mission today is to give you, the learner, the ultimate high -yield deep dive into Chapter 7, Reproductive Health, from Perry's Maternal Child Nursing Care in Canada.

We're going to distill the key information you need for clinical practice.

We're talking the anatomical details that actually matter for patient outcomes, simplifying those hormonal cycles, and really prioritizing the assessment and care for the most common issues, you know, pain, bleeding, infections, and breast concerns.

And this is so important in the Canadian context because these issues,

from, you know, managing debilitating dysmenorrhea to preventing the long -term effects of STIs, these are the primary reasons patients in their reproductive years are coming to see you.

You need a comprehensive, targeted understanding for assessment, for intervention, and I would argue most critically, for patient education.

That's half the battle in this field.

It really is.

So to lay out our roadmap, this chapter has about 12 core objectives, but we're going to focus on the clinical application of each one.

We'll cover the structures, but only the ones that are truly essential for, say, assessment or the mechanics of birth.

Right, the need -to -know stuff.

Exactly.

We'll differentiate the menstrual cycles, but we'll do it through the lens of pain and bleeding disorders.

And maybe most importantly, we will highlight the evolving Canadian standards for things like STI prevention and breast health screening.

Our goal is to make sure you walk away knowing exactly what facts jump off the textbook page and write into a life -saving clinical decision.

I love that.

Okay, so let's start with the basics then.

The structures.

We'll begin externally with the vulva, which is everything you can see from the Mons pubis down to the perineum.

Now, I know we can all memorize the list, labia majora, menorah, clitoris, but what's the most important takeaway for a nurse who's doing a physical assessment?

The key nursing application, the thing you have to internalize, is the recognition of normal variation.

Appearance is so individual.

It's influenced by heredity, age, race, and parity, how many children someone has had.

For instance, the labia majora often flatten and spread out a bit after childbirth.

Totally normal.

Right.

You also note structures like the foreshet, that delicate little thin tissue junction right below the vaginal opening.

It's important because it's a common sight for tearing during childbirth.

And what about the glands, the bartholin and the skein glands?

They're crucial because they secrete mucus for lubrication.

Their clinical importance really comes up when they get blocked because that can form some really painful cysts or abscesses.

Okay, so moving inward to the core structures.

The vagina.

The vagina.

It's a fibromuscular tube and it sits right between the bladder and the rectum, but the design of it is just fascinatingly functional.

During the reproductive years, its walls have these transverse folds called rugae.

Rugae.

And why are those so important?

Because they allow the vagina to expand significantly.

I mean, they accommodate both penile penetration and, critically, childbirth.

It's an incredible design.

And what happens when estrogen levels drop?

Well, after childbirth or during lactation or at menopause, those estrogen levels fall and the walls thin out, the rugae flatten.

And that can lead to issues like atrophic vaginitis.

Okay.

Also, a vital detail for you.

The vaginal secretions are maintained at a slightly acidic pH, usually between 4 and 5.

And that's a defense mechanism?

It's the body's natural defense against infection.

It works mainly by inhibiting the growth of pathogenic bacteria.

And then we have the uterus, right?

Supported by those cardinal and uterus sacral ligaments divided into the corpus, which includes that dome -shaped top part, the fundus, and then the lower part, the cervix.

And the uterus is the workhorse.

Its job is reception, implantation, retention,

nutrition for the fertilized ovum, and of course, cyclic menstruation.

But this is where figure 7 .3 comes in, the illustration of the uterine wall.

You've got the endometrium, which is the inner lining that sheds, the myometrium, which is the big middle muscle layer, and then the outer peritoneum.

But you've said we have to really spend some time on the myometrium.

We have to.

If I'm a student prioritizing what I need to know for a high -risk scenario, this is it.

The structure of this middle layer is so high up on the list, it's not just a descriptive diagram.

So why?

Why is it so important?

Because it is the anatomical basis for preventing the number one killer in the postpartum period, postpartum hemorrhage, PPH.

The middle layer of the myometrium has these smooth muscle fibers that extend in three directions, but the critical ones are interlaced in this unique figure 8 pattern.

A figure 8 pattern.

Wait, so the uterine muscle isn't just for pushing during labor, it's also acting like a tourniquet afterwards.

That is the perfect analogy.

Exactly.

Think about it.

When the fetus is born and the placenta detaches, you have these massive open blood vessels that were supplying that placental site.

Right.

A huge wound, basically.

A huge wound.

But when the hormone oxytocin is released, it pauses these figure 8 muscle fibers to contract powerfully.

They act as living ligatures.

They literally encircle and mechanically compress the blood vessel.

That's incredible.

It's the essential mechanism for controlling blood loss and achieving hemostasis.

So if the uterus is fatigued or boggy, what we call uterine adenine, those ligatures fail, the vessels stay open, and the patient can hemorrhage incredibly quickly.

Understanding that figure 8 pattern shifts the knowledge from just anatomical trivia to a top nursing priority in every single vaginal birth.

That makes perfect clinical sense.

Okay.

So zooming in on the lower part, the cervix.

The cervix is mainly fibrous connective tissue.

That's what allows it to stretch and efface so dramatically during labor.

But for non -pregnant health, we really need to focus on the transformation zone.

The transformation zone.

What is that?

It's also called the squamocolumbar junction.

It's where the outer squamous epithelium meets the inner columnar epithelium.

This zone is constantly regenerating, which unfortunately makes it the single most common site for neoplastic changes, for cancer.

And that's why the PAP test targets that specific area.

Precisely.

You are literally sampling the highest risk area for cervical cancer screening.

Moving laterally, we have the uterine tubes or the fallopian tubes, the bridge between the ovaries and the uterus.

Right.

And the tubes are segmented, but you really only need to know two key locations.

First is the ampulla.

The ampulla.

That's the outer part of the tube where fertilization usually happens.

And second is the infundibulum, which has these fringed ends called fimbria.

And the fimbria are like little fingers.

They are.

They're constantly sweeping over the ovary, helping to pull the ovum into the tube right after it's released.

Any blockage or scarring in these tubes, often from an infection like chlamydia, can lead to major complications like an ectopic pregnancy or infertility.

And finally, the ovaries themselves.

Multifunctional powerhouses.

Their two main jobs are ovulation releasing a mature ovum and hormone production, specifically estrogen, progesterone, and a little bit of androgen.

And they physically change over time, don't they?

They do.

They're smooth before menarche, but they become visibly nodular after menarche.

And that's because of the repeated rupturing of follicles during every ovulatory cycle.

Okay, so we can't forget the container that holds all this vital anatomy.

The bony telvis.

Four bones providing protection, support, and of course, the passage for birth.

For maternal child nursing, the concept of the true pelvis versus the false pelvis is vital for understanding labor.

It's not just a line on a diagram.

Break that down for us.

The false pelvis is the upper, broader section.

Its main job is to support the weight of the enlarging uterus during pregnancy.

But the true pelvis, that's the lower curved bony canal.

The birth canal.

The birth canal.

It's composed of the inlet, the cavity, and the outlet.

And it's the specific dimensions and the shape of this canal that will dictate whether a vaginal birth is even mechanically possible.

Let's shift our focus up now to the breasts.

Their paired mammary glands integral to reproductive function, but also, unfortunately, a significant source of health concerns for many people.

And their development is entirely driven by hormones.

Figure 7 .7 in the text shows the internal structure really clearly.

Estrogen stimulates the growth of the ducts.

It causes fat deposition, and it increases vascularity.

And progesterone.

Progesterone causes the final maturation of the lobules in the assini, and those are the structures that actually secrete colostrum and milk.

And the text mentions Cooper's ligaments.

Yes, those are the fibrous suspensory ligaments.

They provide support, but they also allow for mobility.

And then you have the myoepithelium, which is contractile tissue surrounding the assini that contracts to expel milk when it's stimulated.

And this brings us to what you call the aha moment, the clinically essential insight that tells us the best time for a breast assessment, because it links the breasts directly back to the menstrual cycle.

Right, because the normal physiological changes are cyclical.

In the several days before menstruation, you have rising levels of estrogen and progesterone.

This leads to water retention, swelling, and increased nodularity.

So lumps and tenderness get worse right before your period.

Exactly, which is why an assessment during that phase is really unreliable.

The most important clinical timing is this.

The breasts reach their minimum size and have the least amount of hormonal influence approximately five to seven days after menstruation stops.

And that's the sweet spot.

That is the optimal time for both patient self -awareness and for a clinical examination.

Okay, moving from structure to function,

the menstrual cycle.

It all starts with menarche, the first period, which on average is around age 13 in North America.

Puberty is, of course, the larger transitional phase.

What is the biggest warning shot we need to fire at adolescents and their parents about those first few years of periods?

That they are initially misleadingly easy.

Those early periods are typically irregular, they're often painless, and crucially, they are inovulatory, meaning no egg is being released.

It can take a year, sometimes more, for that complex hypothalamic -pituitary axis to fully mature and establish a regular, predictable, ovulatory rhythm.

And this leads to a critical nursing education point.

It does.

You have to stress that an ovum can be released at any time after menarche begins, and therefore pregnancy can occur at any time.

They are not safe just because their periods are irregular.

Got it.

Okay, so the menstrual cycle.

It's this continuous conversation between four systems averaging about 28 days.

Day one is always the start of menses.

Let's try to simplify this hormonal feedback clip.

The diagram in figure 7 .8 can be a little overwhelming with all the acronyms.

Can you give us an analogy to anchor the process?

Let's use a chain -of -command analogy.

It starts when the hypothalamus, who is the CEO, sees that estrogen and progesterone levels are low, so it releases the starting memo, which is GnRH gonadotropin -releasing hormone.

Okay, CEO sends the memo.

GnRH then tells the anterior pituitary, who we'll call the manager, to release a work order.

And that work order is FSH follicle -stimulating hormone.

So FSH stimulates the ovarian follicles to develop.

As they develop, they start producing the building material, estrogen.

So what happens when estrogen levels peak and then start to drop off just a little bit?

That slight drop triggers the pituitary, the manager, to release a different work order, LH, or luteinizing hormone.

This results in a dramatic LH surge, which peaks around day 13 or 14, and that surge is what actually triggers ovulation about 24 to 36 hours later.

So once the LH surge causes the follicle to rupture and the ovum is expelled, the ovarian cycle shifts into its next phase.

Correct.

The ovarian cycle has two phases.

The follicular friates, which is pre -ovulation, it can be variable in length, and it's dominated by FSH and estrogen.

And then the luteal phase, which is post -ovulation, it's almost always a consistent 14 days long.

And the luteal phase is key.

It's so key.

The remnants of that ruptured follicle transform into the corpus luteum, which acts as a temporary hormone factory.

Its job is to secrete large amounts of progesterone and semestrogen to hold the uterine lining ready for a potential implantation.

And if no implantation occurs?

The corpus luteum regresses, hormone levels plummet, and the cycle ends, which triggers menstruation.

Which leads us directly to the endometrial cycle, the preparation and eventual breakdown of the uterine lining, also in four phases.

Right.

So phase one is the menstrual phase, the shedding.

Phase two is the proliferative phase, which is this period of rapid rebuilding and thickening of the lining, and that's driven by estrogen.

Phase three is the secretory phase.

This is when the lining becomes vascular, edematous, really juicy.

It's primed for implantation.

And this phase is dominated by progesterone.

So estrogen builds the house, progesterone prepares the nursery.

Perfect analogy.

And if there's no implantation, you get phase four, the ischemic phase, the spiral arteries vasoconstrict, the tissue dies from lack of oxygen, and shedding starts all over again.

Beyond these major hormonal shifts, patients can track several smaller physiological signs.

The textbook notes basal body temperature, or BBT, and changes in cervical mucus.

BBT is typically low, less than 37 degrees Celsius, before ovulation.

And then it rises immediately after ovulation.

And that's due to the thermogenic or heat producing effect of progesterone from the corpus luteum.

And the cervical mucus.

That's a huge indicator.

Pre - and post -ovulation, it's thick and viscous.

But right at ovulation, under the influence of high estrogen, it becomes thin, clear, and extremely stretchy, like raw egg white.

There's a specific term for that stretchy quality, isn't it?

Yes.

It's called spin mark height.

It's a very descriptive term.

I find it really useful.

Right.

And what about that mid -cycle discomfort some people feel?

That's mittelschmerz.

It's German for middle pain.

It's a localized, often one -sided, lower abdominal discomfort that coincides with the follicle rupturing at ovulation.

Sometimes it's accompanied by a little bit of mid -cycle bleeding, which is just a tiny amount of withdrawal bleeding after estrogen levels briefly drop.

Before we jump into disorders, we have to mention prostaglandins, or PG's.

They seem to be involved in everything from ovulation to sperm transport and, most significantly, menstrual pain.

PG's are key.

They are oxygenated fatty acids that are potent, smooth muscle contractors.

They are what cause the sloughing of the endometrium during menses, and they are the primary drivers of uterine cramps.

They also play a huge role in initiating both term and pre -term labor.

Their function is absolutely central to understanding how we manage dysmenorrhea.

Okay, let's talk about the absence of periods.

Ammonorrhea.

We define primary as no menses by age 15, and secondary as a cessation of periods for six months or more after they've already been established.

For secondary ammonorrhea, the most common cause has to be ruled out first.

Always.

Pregnancy.

Once that's ruled out, the causes fall into broad categories.

Anatomical issues, endocrine disorders like PCOS or thyroid problems, chronic diseases, stress, and importantly, weight extremes.

We often see what's called hypogonotropic ammonorrhea.

This is hypothalamic suppression, and we see it in patients with severe weight loss, eating disorders like anorexia nervosa, or intense emotional stress coupled with really strenuous exercise.

This ties directly into that classic nursing concept, the female athlete triad.

Exactly.

The triad links disordered eating, ammonorrhea, and premature osteoporosis.

You see low bone density that you'd expect to see in a post -menopausal patient, not in a young healthy athlete.

And the nursing intervention here isn't medication.

No, it's purely counseling and education.

Your role is to help them identify and eliminate stressors, correct any dietary deficiencies and weight loss, and modify their exercise regimen.

You also have to caution them that just taking calcium and vitamin D supplements alone often isn't enough to reverse this bone loss.

Now onto what is probably the number one pain complaint,

dysmenorrhea.

We classify this as primary pain associated with ovulatory cycles, typically in younger patients, and secondary, which is pain that develops later and is linked to some kind of underlying pathology.

Primary dysmenorrhea is purely biochemical.

It's caused by the excessive release of a specific prostaglandin, prostaglandin -tex -2 -g -efa -alpha.

And as you said, that's a powerful vasoconstrictor and uterine contractor.

Extremely powerful.

It leads to strong, painful cramping and localized ischemia, which is what you feel is that cyclic lower abdominal pain.

It's also why patients report systemic symptoms like nausea, GI upset, and backache, because PGs act throughout the entire body.

Let's apply this clinical reasoning using the case study from the chapter Sherry, the 16 -year -old whose Advil isn't helping her, really bad cramps.

Since we know the pain driver is PGs, how do we educate her on pharmacological management?

First, we educate her on the mechanism.

We're not just treating the pain, we are blocking the creation of the pain chemical.

So the first line of attack is prostaglandin synthesis inhibitors, in other words, NSAIDs, like ibuprofen or naproxen.

And the key to success is?

Timing.

It's all about the timing.

NSAIDs must be started at the onset of bleeding or prodromal symptoms for them to be maximally effective.

You can't wait until hours later when the pain is already established and the prostaglandin cascade is in full swing.

And the text gives us a specific pathway if that first treatment fails, right?

Yes, there's a clear nursing alert.

It says that if one NSO, like ibuprofen, fails to provide enough relief after a 6 -month trial, you should try a different one, like naproxen.

They're not all the same.

And if that second NSAID also fails?

Or if the patient also needs contraception, then we pivot to combined oral contraceptives or COCs.

Why are COCs so effective for primary dysmenorrhea?

They're highly effective because they work by suppressing ovulation and endometrial growth.

If you have less endometrium, you have less raw material available for prostaglandin synthesis.

This leads to significantly lighter flow and much reduced cramping.

And continuous use is even better.

Yes.

Continuous or extended cycle hormonal contraception is often superior to the cyclical regimens for providing uninterrupted pain relief.

Now if the pain profile changes, if it starts earlier, or radiates, or it feels more like a dull ache, that points us towards secondary dysmenorrhea.

Correct.

Secondary dysmenorrhea, which often appears later in life, strongly suggests there's an underlying pathology.

Things like endometriosis, adenomyosis, uterine fibroids, or pelvic inflammatory disease, PID.

The diagnosis is more complex, it might require ultrasound or laparoscopy, and the treatment has to target that underlying disorder.

Okay, next let's address PMS and its severe variant, PMDD.

The key is that the symptoms have to occur in the luteal phase and then disappear entirely after menses begins, and they have to be affecting the person's lifestyle.

Right.

PMS covers a huge range of symptoms, from fluid retention and breast tenderness to irritability and food cravings.

PMDD, premenstrual dysphoric disorder, is the really severe end of that spectrum.

It affects about 3 to 8 % of people who menstruate.

Box 7 .1 in the text details the diagnostic criteria.

You need at least 5 of 11 specific symptoms, and at least one of those has to be a major mood -related symptom, like severe dysphoria or anxiety.

The cause is so interesting because it requires ovarian function, but the symptoms are primarily neurological and emotional.

It seems to link estrogen fluctuation to serotonin levels.

It does, and the collaborative care approach really starts with lifestyle modifications.

We're talking about eliminating triggers like smoking, salt, sugar, alcohol, and caffeine,

and incorporating daily aerobic exercise, ideally 60 minutes or more, which naturally elevates mood via beta endorphins.

And nutritional supplements.

Things like calcium and vitamin B6 have shown some benefit.

And if lifestyle changes aren't enough, then we move to pharmacology.

SSRI, selective serotonin reuptake inhibitors, like fluoxetine or sertraline, are first line for the emotional symptoms and depression.

They can often just be used during the luteal phase, which is great.

For the physical symptoms, you can use diuretics, NSAIDs, and COCs.

And it's important to note, the text specifically says that progesterone itself is not considered an effective treatment for PMS.

Let's move to endometriosis, which is often called the hidden pain.

This is the presence and growth of endometrial tissue outside the uterus.

And this ectopic tissue still responds to hormones, so it grows, and then it bleeds during menses.

But this bleeding is happening inside the closed pelvic cavity.

Which causes inflammation.

Exactly.

Inflammation, which leads to fibrosis, and the formation of scar tissue and adhesions.

This is why it causes such chronic pain, and why it's a major cause of acquired infertility.

The adhesions can literally pull the uterus into a fixed position, or completely block the fallopian tubes.

Sometimes they form what are called chocolate cysts on the ovaries.

What are the classic symptoms that nurses need to be looking for, and is it true that symptom severity doesn't always match the extent of the disease?

Absolutely true.

The classic symptoms are severe pelvic pain, chronic noncyclic pain, terrible dysmenorrhea, and significantly dysbaryonia, which is painful intercourse.

Bowel symptoms are also very common.

But crucially, the severity of the symptoms does not correlate with the extent of the disease you might see on a laparoscopy.

You can have a patient with massive internal adhesions and only mild pain, or a patient with just a few spots of endo who is in agony.

And the treatment depends entirely on the patient's goals.

Pain management versus future fertility.

Right.

For mild cases, or for those who are actively trying to get pregnant, NSIids are the first step.

If pregnancy is being postponed, then continuous EOCs are used to suppress the tissue.

For severe suppression, we use GnRH agonists like Luperolide or neferalin.

And these drugs induce a state of what you call it, a medically induced menopause.

That's exactly what it is.

It sounds intense, and it is.

So what's the trade -off?

Well, they suppress ovarian function, which causes the ectopic tissue to regress, and that provides significant pain relief.

But the trade -off is menopausal side effects, hot flashes, vaginal dryness, and importantly, transient bone loss.

This is why their use is usually limited to about six months.

And for definitive cure.

If fertility is not desired and the symptoms are just completely debilitating, the only option is a total abdominal hysterectomy with a bilateral salpingo -uforectomy, a TA with BSO.

So the nursing priority here really has to be psychological support, given the chronic nature of this and the high recurrence rate, which is around 40%, especially concerning the dyspareunia.

Absolutely.

This is a chronic illness.

It requires empathetic, long -term counseling,

honesty about the recurrence risks, and sometimes referral for psychological or sexual health support.

Let's briefly cover abnormal uterine bleeding, or AUB.

We have all these descriptive terms like menorrhagia for excessive flow and metorrhagia for bleeding between periods.

The nursing alert here is fundamental.

If your patient considers the amount or duration of bleeding excessive or abnormal, you must investigate.

A really common cause of menorrhagia is uterine gliomyomas, or as most people know them, fibroids.

Which are benign, smooth muscle tumors.

And for fibroids, how is management decided?

It really depends on their size, their location, and the symptoms they're causing.

Often, if they're small and asymptomatic, they're just monitored.

For symptomatic relief, GnRH agonists can be used to temporarily shrink them.

Surgical options can range from a myomectomy, which removes the fibroids but retains child -bearing potential, though it has a high recurrence risk, to a uterine artery embolization or a full hysterectomy.

Box 7 .2 provides this massive list of causes for AUB.

What's the clinical wisdom for navigating that list?

The key takeaway is that the cause is rarely simple.

You always have to rule out pregnancy first.

Then you have to consider systemic issues like thyroid problems or bleeding disorders like von Willebrand's disease, alongside the local anatomical issues like polyps, cancer, or fibroids.

The critical long -term management goal is to prevent chronic unopposed estrogen stimulation, which can happen with persistent inovulation, because that increases the risk for endometrial hyperplasia and atypical changes.

Treatment often involves OCPs, NSAIDs, or the 11 -argestral releasing IUD.

Okay, let's move on to the climatric, the transitional phase in menopause, which is defined as 12 full months without a period.

The average age in North America is around 51 .4 years.

The nursing priority here is the strongest warning we can give, and it is this.

Any post -menopausal bleeding, spotting, or staining, no matter how minimal, must be investigated immediately for endometrial cancer.

Assume it's malignancy until it's proven otherwise.

That's a huge takeaway.

And the symptoms during this transition, which can last for years in what we call perimenopause, include things like hot flashes and night sweats.

Right, vasomotor instability,

also psychological changes like anxiety or irritability, and atrophic vaginitis, which is vaginal dryness due to the loss of estrogen.

Hormone therapy, or HT, is the most effective treatment for those symptoms, but the history of HT has made a lot of patients really wary.

What do nurses need to make sure their patients understand about the risks?

HT, which can be estrogen alone or combined with progestin, is very effective, but it requires a detailed, shared decision -making process.

Patients have to understand the increased risks of breast and ovarian cancer, venous thromboembolism or VTE, and stroke that are associated with its use.

So lifestyle modifications come first?

Always.

We prioritize diet, exercise, limiting triggers like hot beverages or alcohol, and smoking cessation.

And what about complementary and alternative medicine, or CAM options?

We hear a lot about things like black cohosh and soy.

Many patients use CAM, and we have to document it.

Black cohosh and phytoestrogens from soy are popular, but the research showing consistent effectiveness for severe hot flashes is pretty limited, and they should be used with caution.

The nursing role is really to normalize this transition, provide supportive care for the psychological symptoms, and make sure that rigorous cancer screening is maintained.

OK, now we move to STIs, a significant and growing public health challenge in Canada.

Chlamydia, gonorrhea, and syphilis rates are all on the rise, particularly in the younger age groups.

And the consequences is topic pregnancy and fertility are devastating.

Prevention is paramount.

We categorize it as primary and secondary.

Primary prevention is about avoiding the infection in the first place, vaccination, consistent condom use, having fewer partners.

Secondary prevention is prompt diagnosis and treatment to prevent transmission and chronic complications.

Box 7 .4 details common risk factors, including young age, multiple partners, and interestingly serial monogamy, where an infection can spread really rapidly between partners in a sort of closed network.

The nurse's approach to risk assessment, which is in Box 7 .5, is critical.

The assessment has to be non -judgmental.

You have to cover specific risk behaviors, oral, anal, and vaginal sex, their STI history, and any substance use.

When you're counseling, you have to use a risk continuum approach.

Masturbation is low risk, unprotected intercourse is high risk.

And we need to stress that using spermicides with non -oxynol 9 is not protective against most STIs.

In fact, it may even increase HIV risk with frequent use because it can irritate the vaginal walls.

And what about the practical side of prevention?

Negotiating condom use isn't always easy.

Box 7 .7 highlights some negotiation strategies.

We need to teach empowerment, not just give instructions.

This includes strategies like discussing condom use outside of a sexual situation, clarifying personal limits very clearly, and even role -playing how to handle potential partner resistance.

You're teaching the patient how to maintain their boundaries safely.

Okay, let's systematically review the three reportable bacterial STIs, starting with chlamydia, which is the most common.

Chlamydia is the silent but destructive infection.

It gets that name because the vast majority of cases are completely asymptomatic.

But it's still doing damage.

A lot of damage.

The most serious complication is acute salpingitis leading to PID, which can cause tubal factor infertility and a higher risk of ectopic pregnancy.

In newborns, it can cause conjunctivitis and pneumonia.

Diagnosis is via an innate test.

Treatment is either a course of doxycycline or, for adherence concerns, a single dose of azithromycin, and all partners must be treated.

Next up, gonorrhea.

Rates are skyrocketing in Canada, and the biggest challenge with this one is drug resistance.

Gonorrhea is the second most common, and the rates reflect a very serious public health concern, driven in large part by increasing antimicrobial resistance.

Symptoms are often absent, but if they are present, you might see a greenish -yellow discharge or painful menses.

And the diagnosis is a bit different.

Yes.

Diagnosis requires both a culture, which we need for resistance monitoring, and a net test.

Because of the documented resistance, treatment has to be combination therapy, often a ceftriaxone injection, plus oral azithromycin or cefixime.

This is a legally reportable disease, and partner notification is mandatory.

And finally, syphilis, caused by treponema pallidum.

The rates are increasing, and the risk of transplacental transmission and fetal demise during pregnancy is very, very high.

Syphilis has these complex stages.

Primary syphilis is the painless chancre, or ulcer.

Secondary syphilis involves a widespread maculopapular rash, often on the palms and soles, and sometimes the infectious lesion is called condylamatolata.

If it's left untreated, it can progress to latent and tertiary stages, which can cause severe systemic disease and even death.

The treatment is penicillin G, which is preferred for all stages, even in pregnancy.

We have to mention a critical nursing alert related to syphilis treatment in pregnancy, the George -Hirxheimer reaction.

Yes.

This is an acute, systemic febrile reaction that can occur within 24 hours of treatment.

It happens because of the massive release of endotoxins from the dying spirit sheds.

While you can manage it with antipyretics, if it happens in late pregnancy, it can potentially trigger preterm labor.

So patients need to be warned.

Fully advised, they need to monitor for any contractions or changes in fetal movement and seek immediate care if they occur.

All of these infections can culminate in pelvic inflammatory disease, or PID, which is an infection of the upper genital tract.

PID is mostly an ascending spread of microorganisms from the lower tract.

It's predominantly caused by C.

trichomatis, about 50 % of cases, and N.

gonorrhea.

The risk factors mirror those for STIs, particularly young age and multiple partners.

The long -term consequences are severe, chronic pelvic pain, infertility, and ectopic pregnancy.

And the diagnosis of PID relies heavily on clinical criteria.

What are the key findings a nurse should look for?

We look for a triad of symptoms.

Lower abdominal tenderness, bilateral adnexal tenderness, and cervical motion tenderness.

This is often confirmed with other findings, like a fever or abnormal discharge.

Management involves aggressive broad -spectrum antibiotics, usually ceftriaxone, doxycycline, plus metronidazole.

Hospitalization is required for severe cases if the patient is pregnant, if there's a tubo ovarian abscess, or if outpatient treatment fails.

Nursing care requires bed rest in a semi -fowler's position, and really comprehensive education, emphasizing abstinence during treatment and follow -up.

Okay, let's shift to the viral infections.

HPV, human papillomavirus, or genital warts, is the most common viral STI.

Something like 70 to 80 % of adults will get it at some point.

And HPV is so clinically significant because it is the primary cause of cervical neoplasia and cancer.

The lesions themselves are small, soft, sometimes they look like cauliflower.

Diagnosis is usually by a visual inspection and pap testing.

Since no therapy actually eradicates the virus, treatment is focused on wart removal to relieve symptoms.

What is the single most effective public health tool we have against HPV?

Vaccination, without a doubt.

Gardasil 9 is the non -availant vaccine.

It's highly effective, and it's publicly funded across most Canadian jurisdictions specifically for cancer risk reduction.

This is a massive nursing education priority.

Next, genital herpes simplex virus, or HSV.

It's chronic, recurrent, and incurable.

The primary infection is usually the most severe.

You see multiple painful lesions, fever, malaise, and cervicitis.

Recurrences are less severe, usually unilateral, and they're often preceded by a prodromal tingling sensation.

And the risk to a newborn is greatest when?

The risk is greatest when the parent acquires a primary infection during the third trimester of pregnancy.

And management uses antivirals for episodic or suppressive therapy.

Exactly.

Antivirals like acyclover or valacyclover are key.

Suppressive therapy in late pregnancy can significantly reduce the risk of an active outbreak at the time of delivery, and that can potentially prevent the need for a C -section.

Nursing counseling has to be very honest.

Refrain from sex during the prodrome and active lesion stages, and provide psychological support for managing a chronic, incurable condition.

Turning to hepatitis.

HBV is the primary sexually transmitted hepatitis risk, and it can be threatening to the fetus and newborn.

HBV is found in blood, semen, and vaginal secretions.

Screening for hepatitis B surface antigen, or HBSAG, is required for all pregnant patients at their first prenatal visit.

The key prevention strategy is vaccination.

We have universal vaccination for newborns and school -based programs.

For secondary prevention, infants born to HBV -positive parents must receive both the first dose of the vaccine and hepatitis B immunoglobulin, HBIG, within 12 hours of birth.

And it's important to note, breastfeeding is not contraindicated with chronic HBV.

We should also briefly note HCV and Zika.

Right.

HCV is mainly transmitted via sharing drug use equipment and can lead to chronic liver disease.

There's no vaccine, but there are effective treatments.

Zika is not established in Canada, but it can be sexually transmitted via semen, and it poses a major risk of microcephaly to the fetus.

Male travelers who've been exposed should use condoms for three months after their exposure.

And finally,

HIV, human immunodeficiency virus.

ART has made this a chronic, manageable condition, but screening and counseling remain absolutely vital.

Screening now uses fourth -generation tests.

Testing must be voluntary, especially in pregnancy.

Perinatal transmission can happen in utero, during birth, or through breast milk.

The nursing alert regarding counseling is critical here.

Pre -test counseling must ensure informed consent and a real understanding of the risks.

Post -test counseling for a positive result has to cover risk reduction, immediate medical referral, public health notification because it's reportable, and the legal and ethical implications of disclosing the diagnosis to partners and providers.

Okay, let's quickly differentiate the three common local vaginal infections.

We have to be able to tell the difference between a true infection, vaginitis, and normal discharge, which is leukemia.

The three common ones are bacterial vaginosis, BV, candidiasis, or a yeast infection, and trichomoniasis.

Nurses rely heavily on Table 7 .4, which details the wet smear and pH findings for an accurate diagnosis.

Okay, so what are the three quick differential characteristics we need to confirm the diagnosis?

Let's say odor, pH, and what you see under the microscope.

Okay, BV is the most common vaginitis.

It's an overgrowth of anaerobes replacing the good lactobacilli.

The key characteristics,

a fishy odor, a high pH of over 4 .5, and the presence of clue cells under the microscope.

Treatment is oral metronidazole, and the caution here is no alcohol during or for 24 hours after treatment because of severe adverse effects.

And for a yeast infection or candidiasis?

Intense itching or pruritus, a thick, white cottage cheese -like discharge.

The pH is normal and acidic, less than 4 .5, and you see pseudohyphae or buds on the slide.

Treatment is with antifungals.

And lastly, trichomoniasis.

Trich is almost always an STI.

You'll see a coquious, malodorous, greenish -yellow discharge.

The pH is high, over 5 .0, and under the microscope you can actually see the flagellated protozoa moving around.

Treatment is a single dose of metronidazole.

And for trich, the partner must be treated to prevent recurrence.

Okay, our last section.

Concerns of the breast.

Approximately 50 % of adult patients will have a breast concern at some point in their lives.

We need to be expert differentiators between what's benign and what's malignant.

Fibrocystic changes are the most common benign issue.

This is lumpiness and tenderness that is often bilateral, it's diffuse, and it strictly worsens premenstrally.

That's because of hormone fluctuation and water retention.

A diagnosis with ultrasound or aspiration will confirm that it's fluid -filled.

Management is supportive, a low -fat diet, NSAIs, supportive bras, sometimes limiting caffeine.

And how do we differentiate that from a fibrodinoma?

Cable 7 .5 is really crucial here.

Fibrodinomas are the most common tumor in adolescents and young adults.

They are discreet, usually solitary, they're non -tender, and they are highly movable.

They feel like little rubbery marbles under the skin.

And crucially, they do not increase in size cyclically with the menstrual cycle.

The difference in mobility, consistency, and that timing of tenderness is what guides our assessment and referral.

What kind of nipple discharge should immediately trigger a concern for a nurse?

Most discharge is physiological.

It has to be elicited.

It's usually bilateral, something like galacteria, which is milky.

We worry intensely about spontaneous, unilateral, bloody, or serious discharge.

That is the characteristic sign of an intradical papilloma, which is a rare, benign condition, but one that has to be promptly investigated to rule out relignancy.

And the most serious concern, of course, is breast cancer.

It's the second -leading cause of cancer death in Canadian women, with a 1 in 8 lifetime risk.

Early detection improves the prognosis dramatically.

Box 7 .9 lists the critical risk factors.

Family history, having BRCA1 or 2 mutations which can carry up to an 85 % risk, having dense breasts, early menarche or late menopause, nulliparity, certain types of HRT or OCP use, alcohol obesity, and inactivity.

Genetic counseling is highly individualized for those with BRCA mutations because of the intense psychological consequences.

We have to discuss the screening guidelines in the Canadian context because they've changed significantly, and this represents a major shift in nursing education.

This is a huge nursing priority update.

Routine breast self -examination, or BSE, is no longer recommended for screening by Canadian guidelines.

That's a big change.

A very big change.

The data shows it doesn't save lives, and it leads to a lot of unnecessary biopsies and anxiety.

Clinical breast examination, or CBE, is also not routinely recommended for low -risk patients.

The focus has really shifted away from a structured examination to clinical awareness patients knowing what their breasts normally look and feel like and reporting any unusual changes.

And mammography remains the standard.

What are the key age guidelines in Canada?

Screening mammography is the recommended method for early detection.

For low -risk women aged 50 to 69, screening is recommended every two to three years.

For the 40 to 49 age group, screening is based on individualized risk factors and a process of shared decision -making with their provider.

And as nurses, we also have to address cultural barriers to screening, like modesty concerns or language, using culturally sensitive interventions to make sure there's equitable access.

And finally,

confirmation.

When a lump is suspicious, what is the key information the doctors are looking for through a tissue evaluation?

They're seeking confirmation via a diagnostic mammogram, ultrasound, and then a biopsy, either a fine needle aspiration or a core needle biopsy.

Crucially, they test the tissue for receptors.

Estrogen, ER, and progesterone PR receptor -positive tumors respond better to hormone therapy.

They also test for hertenewu, which is an aggressive growth hormone present in about 18 to 20 percent of cases, and that guides targeted therapy.

Treatment is highly customized based on the stage, nodal involvement, and that receptor status.

So to synthesize the most critical points for you, the nursing student, as you head into clinical practice.

First, anatomy for safety.

That figure eight pattern of the myometrium is absolutely crucial for postpartum hemostasis.

You must know how to assess for uterine atony after a birth.

Second, pain management.

Primary dysmenorrhea is directly linked to prostaglandin release.

NSAIDs taken at the onset of symptoms and COCs are the effective pharmacological solutions.

Third, STI prioritization.

STIs are on the rise in Canada.

They carry significant morbidity PID infertility.

Your role is nonjudgmental counseling, risk assessment, emphasizing prevention like vaccination and condoms and ensuring partner treatment for reportable diseases.

Fourth, the endometrial odor.

Any postmenopausal bleeding must be investigated for cancer, period.

And similarly, AUB treatment has to prevent chronic unopposed estrogen hyperstimulation.

And fifth, evolving standards.

Routine breast self -examination, BSE, is no longer recommended for screening.

The focus is now on clinical awareness and adherence to screening mammography guidelines for those aged 50 to 69.

So what does this all mean?

The female reproductive system is inherently complex, right?

It's driven by this intricate hormonal feedback loop.

Your deep understanding of the normal cycle, the ebb and flow of hormones, the structure of the true pelvis, the physiology of breast changes, that is the baseline that empowers you to spot the earliest signs of the abnormal.

Whether that's a non -cyclic lump or chronic pelvic pain or unexplained bleeding,

every single patient you encounter is going to require care that's tailored to her unique hormonal status and her unique life stage.

We wish you the best as you continue your journey into maternal child nursing and be sure to explore those additional resources, CATI, Sex and You, the PHAC guidelines, to keep your Canadian recommendations current and clinically sharp.

We'll catch you on the next Deep Dive.